Janssen is now
Leading where medicine is going
New Identity. Same Purpose.
CANADA change location▼
English | Español Français | Português (BR) Italiano | 한국어 РУССКИЙ
English
English | 中文
中文
日本
한국어
Deutsch
English | Français | Nederlands
Български
HRVATSKI
Čeština
Dansk
Suomi
Français
ΕΛΛΗΝΙΚΑ
Magyar
עברית
Italiano
Русский
Nederlands
Norsk
Polski
Português
Română
SRPSKI
SLOVENČINA
Slovenščina
Español
Svensk
Deutsch | Français
Türkçe
ESPAÑOL
Spanish | English
English | Français
VISIT JANSSEN GLOBAL
Treatments that give hope and health to patients and their loved ones
Access to medical information about products supported by Janssen
Johnson & Johnson Family of Companies in Canada Website Accessibility Statement
Important Safety Information on IMBRUVICA (ibrutinib) and the Risk of Serious and Fatal Cardiac Arrhythmias or Cardiac Failure
Please visit Our Products to review previous safety communications by product.
This site is a resource for Canadian Healthcare Professionals to access Janssen Medical Education events and related information.